miRNAs from mesenchymal-stem-cell-derived extracellular vesicles: Emerging players in regenerative medicine and disease therapy

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

• Level A · Stronger Clinical Evidence
• Level B · Emerging clinical evidence with positive signals
• Level C · Early human research exploring benefits
• Level D · Scientific groundwork from lab and animal studies
• Emerging · Emerging topic under active research

Abstract (original English)

Mesenchymal stem cells (MSCs) hold immense promise in regenerative medicine due to their unique capabilities, including differentiation into various cell types and paracrine signaling. Among their secretions, extracellular vesicles (EVs) play a pivotal role in mediating therapeutic effects through their bioactive cargo, including microRNAs (miRNAs). These miRNAs are key regulators of gene expression, modulating critical biological processes such as inflammation, immune response, and tissue repair. MSC-derived EVs have demonstrated significant therapeutic potential across diverse diseases, including cardiovascular, neurological, autoimmune, and oncological conditions. This review explores the biogenesis, isolation, and characterization of MSC-EVs, with a focus on the functional roles of miRNAs in disease modulation. The therapeutic prospects of MSC-EV miRNAs as potential biomarkers, drug delivery agents, and modulators of pathophysiological pathways are discussed, providing insights into future translational research and clinical applications.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.